E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 12, 2013, Pages 2639-2652

  Lochab, Savita ^a   Pal, Pooja ^a   Kapoor, Isha ^a   Kanaujiya, Jitendra Kumar ^a   Sanyal, Sabyasachi ^a   Behre, Gerhard ^b   Trivedi, Arun Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Fbw7; G CSFR; GSK3 ; Ubiquitin proteasome degradation

Indexed keywords

F BOX AND WD REPEAT DOMAIN CONTAINING 7 PROTEIN; F BOX PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; SMALL INTERFERING RNA; STAT3 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CELL; MYELOID PROGENITOR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SEVERE CONGENITAL NEUTROPENIA; UBIQUITINATION;

EID: 84881117483     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.06.018     Document Type: Article

References (48)

1. Lieschke G.J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., Fowler K.J., Basu S., Zhan Y.F., Dunn A.R. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994, 84:1737-1746.
2. Avalos B.R. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996, 88:761-777.
3. Hunter M.G., Avalos B.R. Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia. Blood 1999, 93:440-446.
4. Valentino L., Pierre J. JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem. Pharmacol. 2006, 71:713-721.
5. Yu C.L., Jin Y.J., Burakoff S.J. Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. J. Biol. Chem. 2000, 275:599-604.
6. Hunter M.G., Jacob A., O'Donnell L C., Agler A., Druhan L.J., Coggeshall K.M., Avalos B.R. Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia. J. Immunol. 2004, 173:5036-5045.
7. Piper M.G., Massullo P.R., Loveland M., Druhan L.J., Kindwall-Keller T.L., Ai J., Copelan A., Avalos B.R. Neutrophil elastase downmodulates native G-CSFR expression and granulocyte-macrophage colony formation. J. Inflamm. (Lond.) 2010, 7:5.
8. Erkeland S.J., Aarts L.H., Irandoust M., Roovers O., Klomp A., Valkhof M., Gits J., Eyckerman S., Tavernier J., Touw I.P. Novel role of WD40 and SOCS box protein-2 in steady-state distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled proliferation and differentiation signaling. Oncogene 2007, 26:1985-1994.
9. Kile B.T., Schulman B.A., Alexander W.S., Nicola N.A., Martin H.M., Hilton D.J. The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 2002, 27:235-241.
10. Ai J., Druhan L.J., Loveland M.J., Avalos B.R. G-CSFR ubiquitination critically regulates myeloid cell survival and proliferation. PLoS One 2008, 3:e3422.
11. Orlicky S., Tang X., Willems A., Tyers M., Sicheri F. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell 2003, 112:243-256.
12. Welcker M., Orian A., Jin J., Grim J.E., Harper J.W., Eisenman R.N., Clurman B.E. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9085-9090.
13. Yada M., Hatakeyama S., Kamura T., Nishiyama M., Tsunematsu R., Imaki H., Ishida N., Okumura F., Nakayama K., Nakayama K.I. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 2004, 23:2116-2125.
14. Wei W., Jin J., Schlisio S., Harper J.W., Kaelin W.G. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer cell 2005, 8:25-33.
15. Inuzuka H., Shaik S., Onoyama I., Gao D., Tseng A., Maser R.S., Zhai B., Wan L., Gutierrez A., Lau A.W., Xiao Y., Christie A.L., Aster J., Settleman J., Gygi S.P., Kung A.L., Look T., Nakayama K.I., DePinho R.A., Wei W. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011, 471:104-109.
16. Bengoechea-Alonso M.T., Ericsson J. The ubiquitin ligase Fbxw7 controls adipocyte differentiation by targeting C/EBPalpha for degradation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11817-11822.
17. Liu H.K., Perrier S., Lipina C., Finlay D., McLauchlan H., Hastie C.J., Hundal H.S., Sutherland C. Functional characterisation of the regulation of CAAT enhancer binding protein alpha by GSK-3 phosphorylation of Threonines 222/226. BMC Mol. Biol. 2006, 7:14.
18. Liu N., Li H., Li S., Shen M., Xiao N., Chen Y., Wang Y., Wang W., Wang R., Wang Q., Sun J., Wang P. The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs. J. Biol. Chem. 2010, 285:18858-18867.
19. Zhao D., Zheng H.Q., Zhou Z., Chen C. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Cancer Res. 2010, 70:4728-4738.
20. Sundqvist A., Bengoechea-Alonso M.T., Ye X., Lukiyanchuk V., Jin J., Harper J.W., Ericsson J. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab. 2005, 1:379-391.
21. Welcker M., Singer J., Loeb K.R., Grim J., Bloecher A., Gurien-West M., Clurman B.E., Roberts J.M. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell 2003, 12:381-392.
22. Olson B.L., Hock M.B., Ekholm-Reed S., Wohlschlegel J.A., Dev K.K., Kralli A., Reed S.I. SCFCdc4 acts antagonistically to the PGC-1alpha transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis. Genes Dev. 2008, 22:252-264.
23. Pal P., Kanaujiya J.K., Lochab S., Tripathi S.B., Bhatt M.L., Singh P.K., Sanyal S., Trivedi A.K. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562. Proteomics 2011, 11:1517-1529.
24. Moucadel V., Constantinescu S.N. Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors. J. Biol. Chem. 2005, 280:13364-13373.
25. Welcker M., Orian A., Grim J.E., Eisenman R.N., Clurman B.E. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr. Biol. 2004, 14:1852-1857.
26. Kang T., Wei Y., Honaker Y., Yamaguchi H., Appella E., Hung M.C., Piwnica-Worms H. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer cell 2008, 13:36-47.
27. Kanaujiya J.K., Lochab S., Kapoor I., Pal P., Datta D., Bhatt M.L., Sanyal S., Behre G., Trivedi A.K. Proteomic identification of Profilin1 as a co-repressor of estrogen receptor alpha in MCF7 breast cancer cells. Proteomics 2013 Apr 10, (in press), http://dx.doi.org/10.1002/pmic.201200534.
28. Pal P., Lochab S., Kanaujiya J.K., Kapoor I., Sanyal S., Behre G., Trivedi A.K. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPalpha for ubiquitin-mediated proteasome degradation. Cell Death Dis. 2013, 4:e590.
29. Trivedi A.K., Bararia D., Christopeit M., Peerzada A.A., Singh S.M., Kieser A., Hiddemann W., Behre H.M., Behre G. Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene 2007, 26:1789-1801.
30. Lochab S., Pal P., Kanaujiya J.K., Tripathi S.B., Kapoor I., Bhatt M.L., Sanyal S., Behre G., Trivedi A.K. Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells. Proteomics 2012, 12:1363-1377.
31. Hao B., Oehlmann S., Sowa M.E., Harper J.W., Pavletich N.P. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol. Cell 2007, 26:131-143.
32. Mao J.H., Kim I.J., Wu D., Climent J., Kang H.C., DelRosario R., Balmain A. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 2008, 321:1499-1502.
33. Grim J.E., Gustafson M.P., Hirata R.K., Hagar A.C., Swanger J., Welcker M., Hwang H.C., Ericsson J., Russell D.W., Clurman B.E. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J. Cell Biol. 2008, 181:913-920.
34. Guchhait P., Tosi M.F., Smith C.W., Chakaraborty A. The murine myeloid cell line 32Dcl3 as a model system for studying neutrophil functions. J. Immunol. Methods 2003, 283:195-204.
35. Schuster C., Forster K., Dierks H., Elsasser A., Behre G., Simon N., Danhauser-Riedl S., Hallek M., Warmuth M. The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate. Blood 2003, 101:655-663.
36. Fenteany G., Schreiber S.L. Lactacystin, proteasome function, and cell fate. J. Biol. Chem. 1998, 273:8545-8548.
37. Scotti E., Calamai M., Goulbourne C.N., Zhang L., Hong C., Lin R.R., Choi J., Pilch P.F., Fong L.G., Zou P., Ting A.Y., Pavone F.S., Young S.G., Tontonoz P. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor. Mol. Cell. Biol. 2013, 33:1503-1514.
38. Mitsui T., Watanabe S., Taniguchi Y., Hanada S., Ebihara Y., Sato T., Heike T., Mitsuyama M., Nakahata T., Tsuji K. Impaired neutrophil maturation in truncated murine G-CSF receptor-transgenic mice. Blood 2003, 101:2990-2995.
39. Jope R.S. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 2003, 24:441-443.
40. McLemore M.L., Grewal S., Liu F., Archambault A., Poursine-Laurent J., Haug J., Link D.C. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 2001, 14:193-204.
41. Ward A.C., Smith L., de Koning J.P., van Aesch Y., Touw I.P. Multiple signals mediate proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells. J. Biol. Chem. 1999, 274:14956-14962.
42. Chakraborty A., Tweardy D.J. Stat3 and G-CSF-induced myeloid differentiation. Leuk. Lymphoma 1998, 30:433-442.
43. Valtieri M., Tweardy D.J., Caracciolo D., Johnson K., Mavilio F., Altmann S., Santoli D., Rovera G. Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J. Immunol. 1987, 138:3829-3835.
44. Zhang W., Koepp D.M. Fbw7 isoform interaction contributes to cyclin E proteolysis. Mol. Cancer Res. 2006, 4:935-943.
45. Dong F., Brynes R.K., Tidow N., Welte K., Lowenberg B., Touw I.P. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N. Engl. J. Med. 1995, 333:487-493.
46. Dong F., Dale D.C., Bonilla M.A., Freedman M., Fasth A., Neijens H.J., Palmblad J., Briars G.L., Carlsson G., Veerman A.J., Welte K., Lowenberg B., Touw I.P. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 1997, 11:120-125.
47. Gregory M.A., Qi Y., Hann S.R. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J. Biol. Chem. 2003, 278:51606-51612.
48. Hermans M.H., van de Geijn G.J., Antonissen C., Gits J., van Leeuwen D., Ward A.C., Touw I.P. Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood 2003, 101:2584-2590.